|
Volumn 33, Issue 12, 2006, Pages 1513-1516
|
Data acquisition and analysis: The strength of methodology in nuclear medicine and molecular imaging
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHETAMINE;
CARBON 11;
CYSTEINE ETHYL ESTER TC 99M;
FLUMAZENIL;
FLUORODEOXYGLUCOSE F 18;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;
OXYGEN 15;
RACLOPRIDE C 11;
WATER;
ADULT;
ALGORITHM;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
BRAIN;
CENTRAL NERVOUS SYSTEM DISEASE;
CONGESTIVE HEART FAILURE;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
FEMALE;
GATED IMAGING;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE MASS;
HEART MUSCLE PERFUSION;
HEART VENTRICLE REMODELING;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MOLECULAR IMAGING;
NEUROIMAGING;
NONHUMAN;
NUCLEAR MEDICINE;
ONCOLOGY;
POSITRON EMISSION TOMOGRAPHY;
REVIEW;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THREE DIMENSIONAL IMAGING;
CARDIOLOGY;
DIAGNOSTIC IMAGING;
HUMANS;
NEUROLOGY;
NUCLEAR MEDICINE;
POSITRON-EMISSION TOMOGRAPHY;
RADIATION ONCOLOGY;
STATISTICS AS TOPIC;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 33845354326
PISSN: 16197070
EISSN: None
Source Type: Journal
DOI: 10.1007/s00259-006-0272-6 Document Type: Review |
Times cited : (3)
|
References (7)
|